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Abstract
The broad area of magnetic iron oxide nanoparticle (M-IONP) applications and their 
exclusive physico-chemical characteristics (superparamagnetic properties per se, solu-
bility and stability in aqueous solutions, and high bioavailability in vivo) make these 
nanoparticles suitable candidates for biomedical uses. The most employed magnetic 
iron oxides in the biomedical field are magnetite and maghemite. Cancer represents 
a complex pathology that implies multiple mechanisms and signaling pathways, this 
complexity being responsible for the increased resistance to therapy and the lack of an 
effective curative treatment. A potential useful alternative was considered to be the use 
of magnetic iron nanoparticles. The M-IONPs proved to be effective as contrast agents in 
magnetic resonance imaging, as drug delivery carriers for different therapeutic agents, 
in magnetic cell separation assays, and are suitable to be engineered in terms of size, 
targeted delivery and substance release. Moreover, their in vivo administration was con-
sidered safe, and recent studies indicated their efficiency as anticancer agents. This chap-
ter aims to furnish an overview regarding the physico-chemical properties of M-IONPs 
(mainly magnetite, maghemite and hematite), the synthesis methods and their in vitro 
biological impact on healthy and cancer cell lines, by describing their potential mecha-
nism of action—enucleation, apoptosis or other mechanisms.
Keywords: magnetic iron oxide nanoparticles (M-IONPs), cancer, enucleation, 
apoptosis, magnetite, maghemite, combustion method
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
1. Introduction
Due to the wide potential of applications in various fields, such as biotechnology, bio-
medicine, magnetic fluids, catalysis, magnetic data recording and storage media, magnetic 
resonance imaging, magnetic fluid hyperthermia, magnetic drug delivery, cell separation, 
magnetic paper and more recently in environmental protection, magnetic iron oxide nanopar-
ticles (M-IONPs) are the main components of the modern technology [1–15]. In nature, many 
forms of iron oxides are found, but the most technologically used are the magnetite (Fe
3
O
4
), 
maghemite (γ-Fe
2
O
3
) and hematite (α-Fe
2
O
3
) (Figure 1).
Magnetite (Fe
3
O
4
), a natural mineral known as the black iron oxide, is relatively stable at room 
temperature, very quickly transforms in maghemite and shows the strongest magnetism com-
pared to other transition metal oxides [16]. Fe
3
O
4
 has an inverse spinel structure with all the 
Fe2+ ions and half of the Fe3+ ions distributed in the octahedral sites and the other half of the 
Fe3+ ions distributed in the tetrahedral sites being surrounded by four oxygen atoms [17].
Spin magnetic moments of Fe3+ ions distributed in octahedral positions are parallely aligned, as 
well as those of Fe3+ ions distributed in tetrahedral positions but in the opposite direction, lead-
ing to an antiparallel coupling. Therefore, the spin moments of all Fe3+ ions mutually cancel out 
and do not contribute to the net magnetization of magnetite (Figure 2). All Fe2+ ions have mag-
netic moments aligned in the same direction so that their total magnetic moment is responsible 
for the net magnetization of magnetite. Therefore, the saturation magnetization of magnetite 
corresponds to the product between the spin magnetic moment of each Fe2+ ion and the num-
ber of Fe2+ ions, which corresponds to the mutual alignment of all Fe2+ ions in magnetite.
Magnetite is oxidized in the presence of air to maghemite, which is also ferrimagnetic, but has 
a slightly lower magnetic response. This process is called maghemitization and occurs at the 
surface of the crystals. Crystal centers are also oxidized, and the process is being carried out 
by diffusion of Fe2+ ions from inside to the surface of the crystals, where they are converted 
to Fe3+. The rate of the oxidation process is determined by the diffusion rate of Fe2+ ions and 
the distance to the surface. Therefore, the particles remain unaffected by the phenomenon of 
maghemitization, while the small ones are susceptible to oxidation even at room temperature.
Figure 1. Crystal structure of: A—hematite, B—maghemite and C—magnetite (the blue sphere is Fe2+/Fe3+ and the red 
sphere is O2−). The structures were adapted after the structures found in the Crystallography Open Database (http://
www.crystallography.net).
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As magnetite, maghemite (γ-Fe
2
O
3
) has a spinel structure with the oxygen ions disposed in a 
closely packed cubic lattice and the iron ions located at interstices. In γ-Fe
2
O
3
 not all the sites 
Figure 2. Spin magnetic moment distribution of Fe2+ and Fe3+ ions in the elemental cell of magnetite.
Property Oxide
Magnetite Maghemite Hematite
Molecular formula Fe
3
O
4
γ-Fe
2
O
3
α-Fe
2
O
3
Color Black Reddish-brown Red
Density (g/cm3) 5.18 4.87 5.26
Melting temperature (°C) 1583–1597 — 1350
Hardness 5.5 5 6.5
Type of magnetism Ferrimagnetic Ferrimagnetic Weakly ferromagnetic/
anti-ferromagnetic
Curie temperature (K) 858 820–986 956
Saturation magnetization 
(M
s
) at 300 K [A·m2/kg]
92–100 60–80 0.3
Standard Gibbs free energy 
of formation ( Δ G 
f
 0 ) [kJ/mol]
−1012.6 −711.1 −742.7
Crystallographic system Cubic Cubic or tetrahedral Rhombohedral, hexagonal
Structure type Inverse spinel Defect spinel Corundum
Lattice parameter (nm) α = 0.8396 α = 0.83474 (cubic); 
α = 0.8347; c = 2.501 
(tetragonal)
α = 0.5034; c = 1.375 (hexagonal); 
α
Rh
 = 0.5427; α = 55.3° (rhombohedral)
Table 1. Physical and magnetic properties of iron oxides [22].
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are occupied, Fe3+ ions are regularly distributed in only two-thirds of the sites and the rest of 
the sites remain vacant. After two sites filled with Fe3+ ions follows one vacant site [18, 19]. 
Maghemite is a metastable oxide, product of magnetite oxidation or a product resulting from 
the heating of other iron oxides.
At temperatures over 300°C, magnetite is oxidized to hematite (α-Fe
2
O
3
)—an anti-ferromag-
netic iron oxide. Hematite (α-Fe
2
O
3
) has a corundum crystal structure with Fe3+ ions distributed 
in octahedral sites and oxygen ions in hexagonal close-packed arrangement. α-Fe
2
O
3
, the final 
product of the transformation of other iron oxides, is a red powder when it is finely divided, 
very stable at room temperature and very widespread in rocks and soils (Table 1) [20, 21].
2. Properties of magnetic nanoparticles
2.1. Magnetic behavior
Magnetic iron oxide nanoparticles (M-IONPs), magnetite (Fe
3
O
4
) and maghemite (γ-Fe
2
O
3
) 
are materials with iron-magnetic properties under their Curie temperatures (858 K and 986 K) 
(Table 1). The ferro- and ferrimagnetic compounds in their raw state present a multidimen-
sional magnetic structure, without a permanent magnetic moment. The magnetic properties 
of a material depend on following parameters: (i) temperature, (ii) pressure and (iii) applied 
magnetic field. The properties of iron oxide nanoparticles by their usual sizes are not similar 
to the properties of larger scale compounds, which explain their use and interest in nano-
medicine [23]. In order to define the behavior of the magnetic field, the key lays in the size and 
distribution of nanoparticles morphology [24]. A spherical, small nanoparticle made of soft 
materials with a diameter below the domain size shows an expendable magnetic anisotropy, 
so that their magnetic moment is free to rotate relatively to the particle and is thus superpara-
magnetic, i.e., paramagnetic under the Curie temperature [25]. The direction of the magnetic 
moment of the nanoparticles is determined by thermal fluctuation and the magnetic anisot-
ropy, which tend to fixate on the crystalline structure or particle morphology [26].
The interaction between an external magnetic field and the magnetic field of a nanoparticle 
determines: (i) the orientation of the magnetic moment of the particle as to become paral-
lel with the magnetic field applied to minimize energy and bipolar interaction and (ii) the 
transition of the particle in the direction of the gradient, as in magnetophoresis [26]. Many 
applications of the magnetic nanoparticles are based on their ability to be manipulated using 
magnetic fields. This capability depends on the effectiveness of the magnetophoretic force, 
determined by the time of the particle and the magnetic field gradient, to fasten or to move 
the particle [25]. The magnetophoretic force exercised over superparamagnetic nanoparticles 
with a single core is less effective due to their small diameter and magnetic moment, but in 
the case of multicore particles, the magnetic momentum induced in the field is strong enough 
to allow magnetic targeting to moderate values of the magnetic field intensity and field gra-
dient. Therefore, in order to assess the applicability of magnetic particles or magnetic fixing, 
the magnetic momentum of the particles is more relevant than mass magnetization [25, 27].
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2.2. Size
The size and the size distribution of superparamagnetic iron oxide nanoparticles are impor-
tant parameters for their biological application. Also, their magnetic properties are in close 
touch with their size. It has been demonstrated that the magnetic dipole-dipole interactions 
are significantly reduced in superparamagnetic iron oxide nanoparticles due to their scale 
of r6, r being the radius of the particle [28]. The advantages of using magnetic nanoparticles 
with sizes smaller than 100 nm are due to their surface efficiency to easily attach ligands 
and small settling velocities which give a high stability in suspension and improve tissue 
diffusion. Particles should be small enough to bypass the endothelial reticule system. They 
are supposed to remain in circulation after injection and be able to pass through the capital 
systems, organs and tissues, avoiding the embolus. Particle size is also important for getting 
an effect of improved permeability and retention. For example, particles larger than 10 nm 
may not penetrate the endothelium in physiological conditions, but can enter in pathological 
conditions, such as inflammations or tumors [28].
When magnetic nanoparticles loaded with medicinal substances are injected into the systemic 
circulation, size, morphology and surface charge are the three important parameters for their 
behavior in the bloodstream. Kupffer cells in the liver are very sensitive to both microorgan-
isms and nanoparticles. Plasma proteins can easily adsorb onto their surface nanoparticles, 
depending on their size, surface charging and their morphology. Particles with sizes larger 
than 200 nm or below 10 nm are not suitable due to their absorption by the endoplasmic 
reticulum system [28].
2.3. Charge
Loading surface and biodistribution of superparamagnetic iron oxide nanoparticles play an 
important role in the colloidal stability. Surface charging can be described qualitatively by the 
nature and behavior of surface groups in the solution at a given pH and in the presence of 
an electrolyte. In terms of quantity, it can be measured as an electric potential in the double 
layer of the interfacial surface of the nanoparticles found in a suspension state. A high value 
of zeta potential is an indication of stability in dispersion of superparamagnetic iron oxide 
nanoparticles due to electrostatic interaction. Composition and structure of nanoparticles are 
very important for their interaction with biological fluids. In a known environment, super-
paramagnetic nanoparticle characteristics, such as the chemical composition, both core and 
neural crest cells, its size and size distribution, shape and angles of curvature, its crystal-
line structure, smoothness or surface roughness and hydrophobic or hydrophilic levels, are 
important for their in vivo applications. These features can determine their stationary time in 
the circulatory system [28].
Osaka and his colleagues [29] have reported a correlation between surface charge of magne-
tite nanoparticles and their cellular absorption efficiency on different cell lines. For example, 
a superparamagnetic particle with positive charge showed a greater internalization in human 
breast cancer cells in comparison with those charged negatively, while there was no  difference 
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in the degree of internalization in endothelial cells of human umbilical bladder. Thus, the 
superparamagnetic nanoparticles absorption depends not only on their surface properties 
but also on cell type.
2.4. Surface functionality and colloidal stability
Both the surface chemistry of magnetite particles and its properties are particularly important 
in various applications. Iron atoms at the surface of the magnetite particle that are not bound 
to oxygen atoms act as Lewis acids and coordinate the molecules that can give a pair of elec-
trons. In aqueous systems, these atoms coordinate water molecules that rapidly dissociate 
resulting magnetite with functionalized surface with Fe-OH hydroxyl groups. So, the chem-
istry of the surface of magnetite particles is strongly dependent on the pH value; at low pH 
values, the surface of the magnetite particles is protonated (positively charged), and at high 
pH values, it is negatively charged (Figure 3). The preformed hydroxyl groups on the surface 
of magnetite have amphoteric character; therefore, they can react either as acids or bases [30].
Another problem that arises after obtaining the magnetic iron oxide nanoparticles (M-IONPs) 
is their agglomeration that is installed due to the van der Waals forces and the magnetic forces. 
Nanoparticles without coatings (naked nanoparticles) are not stable in aqueous environ-
ments, easily aggregating and precipitating. After application in vivo, nanoparticles often form 
aggregates in the bloodstream and are retained by the macrophages. Therefore, they must be 
covered with a variety of fragments which have the property to eliminate or minimize their 
aggregation in physiological conditions [31]. The magnetic nanoparticles are coated with an 
impervious wrapper so that oxygen does not reach at the surface of the magnetic nanoparticles 
in order to ensure an effective stabilization of iron oxide nanoparticles. Some stabilizers, such 
as a surfactant or a polymer, usually are added during preparation to prevent the aggregation 
of nanosized particles. Most of these polymers stick to the nanoparticles surface in a specific 
substrate manner. Nanoparticle surfaces can be composed of several organic and inorganic 
materials, including polymer. Also, polymer coating materials can be classified in turn into 
synthetic and natural. Polymers such as poly-ethylene-co-vinyl acetate, poly-vinylpyrrolidone, 
Figure 3. The behavior of Fe
3
O
4
 nanoparticles depending on pH.
Iron Ores and Iron Oxide Materials234
poly-acid-lactic-co-glycolic, polyethylene glycol, etc. are typical examples of synthetic poly-
meric systems. Natural polymer coatings include gelatin, dextran, chitosan, etc. The molecules 
used for stabilization of magnetic nanoparticles must be biocompatible and biodegradable. 
The most common surfactant molecules are oleic acid, lauric acid, acids, sulfonic acids, alkanes 
and alkane phosphonates. The surfactants are amphiphilic compounds and they manifest their 
role at the interface between nanoparticles and solvent. However, magnetic nanoparticles cov-
ered with organic compounds, in suspension cannot be used for biological purposes, espe-
cially in the delivery of medicines. Changing the surface of nanoparticles post-synthesis is 
known as core-shell nanoparticles, also used widely. The most commonly used materials are 
polymers, silica or metals (e.g. gold, cadmium, selenium, silver). Coating materials protect the 
core against oxidation and therefore keep the magnetic property of nanoparticles. It is known 
that the iron oxide nanoparticles are non-toxic, but some coating materials may be toxic. For 
example, silicon dioxide is biocompatible, but is not biodegradable [28].
Many researchers have prepared magnetic nanoparticles covered with various surfactants 
or biomolecules that have been introduced directly in the synthesis process. For example, 
Salavati-Niasari et al. [32] have synthesized Fe
3
O
4
 nanoparticles covered with octanoic acid 
using a facile chemical precipitation method. The surfactant was present in the reaction system 
to improve dispersity. The authors have obtained magnetic nanoparticles with a size range of 
25 nm. Liu et al. prepared magnetic nanoparticles coated with chitosan, for the immobilized 
lipase, using the co-precipitation method. They replaced water with 2% chitosan in acetic acid 
solution during the reaction process [33].
Atomic transfer radical polymerization (ATRP) is another common way to cover magnetic 
nanoparticles, developed by Wang et al. [34]. Due to the magnetic interaction of the iron oxide 
nanoparticles with biological fluids, the process of formation of free radicals of oxygen reac-
tive species may be increased. To protect the environment in vivo from these toxic by-products, 
some materials have been used for biocompatible and rigid coatings, such as gold [28].
3. M-IONPs synthesis methods
In the past decade, numerous synthesis methods have been developed to obtain M-IONPs. 
On the basis that the method of preparation plays an essential role in obtaining nanopar-
ticles with tailored properties, the research work regarding the development of new synthesis 
methods to control the size, shape, morphology and magnetic properties of these nanopar-
ticles is a permanent challenge. In the same time, the synthesis method has to be environ-
mentally friendly, simple, inexpensive and reproducible. Many scientific publications have 
described efficient synthesis methods, which allow the obtaining of monodisperse magnetic 
nanoparticles, stable for a long time with controlled shape.
The synthesis method has to ensure the obtaining of magnetic nanoparticles with specific 
properties to their application domain by changing the experimental reaction conditions. For 
biomedical applications, superparamagnetic iron oxide nanoparticles with a specific surface 
chemistry (for in vivo applications), high magnetization values and a narrow size distribution 
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of the particles with size below 100 nm are needed. Magnetite (Fe
3
O
4
) and maghemite 
(γ-Fe
2
O
3
) have attracted particular attention because, under certain synthesis conditions, they 
are superparamagnetic, being also biocompatible, thus becoming the magnetic nanomaterials 
most commonly used in medical applications.
Hereinafter, the most popular synthesis methods used for obtaining M-IONPs will be 
described. After the chemical surface modification of magnetic nanoparticles by binding 
drugs, proteins, enzymes, antibodies, etc., they can be directed to an organ, tissue or tumor 
with the help of an external magnetic field. The methods described below allow to obtain 
magnetic nanoparticles with narrow size dimensions, desired shape and morphology, by 
changing the conditions and/or parameters of the synthesis. The most used and popular 
method for the synthesis of magnetite, being in the same time simple and efficient, is the 
chemical precipitation of iron salts [35–39].
3.1. Precipitation method
The first synthesis of superparamagnetic iron oxide nanoparticles was reported by Massart, and 
the method consists in mixing two salts of Fe3+ and Fe2+ in a molar ratio of 2:1 in aqueous medium 
followed by precipitation of these salts using a precipitating agent (a base – NH
3
) under inert 
atmosphere or at elevated temperature, resulting a black magnetic precipitate [40]. The equation 
of the chemical reaction which underlies the formation of magnetite may be written as Eq. (1):
  F e 2+    +  2F e 3+    +  8O H −    →  Fe (OH ) 
2
    +  2Fe (OH ) 
3
    →  F e 
3
 O 
4
 ↓   +  4  H 2 O (1)
Magnetite is not stable at room temperature, being sensitive to oxidation in contact with air, 
easily transforming into maghemite, according to Eq. (2):
  2 Fe 
3
 O 
4
  +  1 ⁄ 2   O 
2
  → 3γ −  Fe 
2
 O 
3
 (2)
The precipitation process is based on two steps regarding the formation of the solids [41, 42]: 
(i) nucleation—a very short period, occurs only when the concentration of the constituent spe-
cies reaches suprasaturation and (ii) slow controlled growth of the preformed nuclei, by diffu-
sion from the solutions to the surfaces of the crystal. To avoid the formation of polydispersed 
nanoparticles, it is necessary that the two stages to be separated, i.e., nucleation does not take 
place simultaneously with crystal growth. By controlling the two processes, monodispersed 
magnetic particles can be obtained. If the nuclei start to form in the same time, the growth of 
these nuclei leads to particles with very narrow size distribution. Therefore, the size of the 
obtained particles can be controlled but only in the nucleation step because the size of the 
particles does not change during the growth process.
It has been shown that by controlling both the pH of the reaction medium and the ionic 
strength, it is possible to control the mean size of the particles. Jiang et al. have demonstrated 
that the size of the particles has an inverse proportionality with the pH and the ionic strength 
of the precipitation medium [43]. These two parameters (pH and the ionic strength) also affect 
the chemical surface of the crystals and the electrostatic surface charge [44].
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Other parameters that can influence the size, shape and composition of the magnetic iron 
oxide nanoparticles are the nature of iron salts (chlorides, perchlorates, nitrates, sulfates, 
etc.) and the molar ratio Fe3+/Fe2+. Roth and co-workers published a good analysis regarding 
the influence of the reaction conditions on the formation of superparamagnetic iron oxide 
nanoparticles. The authors demonstrated that for obtaining particles with a size between 3 
and 17 nm with high saturation magnetization a higher reaction temperature, higher iron salt 
concentration, Fe3+/Fe2+ molar ratio below 2 and a molar ratio of hydroxide ions/iron ions of 
1.4:1 are needed [45].
Wu et al. investigated the effect of the vacuum drying method on the change of the morphol-
ogy and magnetic properties of magnetic iron oxide nanoparticles (M-IONPs). They revealed 
that the obtained nanoparticles tend to agglomerate more easily when their average diameter 
decreased, but the structure and morphology are maintained better by ambient air drying. 
They also obtained magnetic nanoparticles with high saturation magnetization after drying 
the obtained nanoparticles in a vacuum at 70°C [36].
The same group of researchers in another study has synthesized Fe
3
O
4
 nanoparticles by utiliz-
ing ultrasonic-assisted chemical co-precipitation. They used high purity iron separated from 
iron ore tailings by an acidic leaching method and obtained superparamagnetic iron oxide 
nanoparticles without a protecting gas [46]. Pereira and co-workers have synthesized super-
paramagnetic Fe
3
O
4
 nanoparticles with small particle size (4.9–6.3 nm) and improved magnetic 
properties by one-step aqueous precipitation route based on the use of a new type of alkaline 
agents [47]. The alkaline agents that they have used include alkanolamines, isopropanol amine 
and diisopropanolamine. The base that they have used, instead of the most used—NaOH, 
leads to smaller particle sizes (up to 6 times) and enhanced saturation magnetization (up to 1.3 
times). Generally, the size of the particles is proportionally with the magnetization saturation, 
but the above results showed improved magnetic properties while keeping their small size.
Besides the many advantages of the precipitation method (high saturation magnetization, 
rapid synthesis with high yield, versatility, nanoparticles with the desired morphology and 
characteristics), it shows several disadvantages, like oxidation, magnetic nanoparticles with 
particle size distribution that cannot be controlled, polydispersion and weak crystallization 
which leads to nanoparticles with low saturation magnetization.
3.2. Thermal decomposition
Thermal decomposition of organometallic compounds in high boiling organic solutions in 
the presence of stabilizers is also a popular method for the synthesis of the spinel structured 
Fe
3
O
4
 and a very promising technique for obtaining high-quality superparamagnetic iron 
oxide nanoparticles. The magnetic nanoparticles obtained by this method proved to be supe-
rior to those obtained by precipitation, because the nucleation process can be separated by the 
growth process and the hydrolysis reaction is avoided [48].
The method is based on the decomposition of an iron precursor at high temperature in the 
presence of solvents which contain stabilizing surfactants (such as oleic acid or oleylamine) 
[49–51]. By varying the reaction mixtures and modifying the synthesis condition, it can be 
Preclinical Aspects on Magnetic Iron Oxide Nanoparticles and Their Interventions as Anticancer…
http://dx.doi.org/10.5772/intechopen.74176
237
obtained M-IONPs with controlled size, size distribution and composition. The most com-
monly used precursors employed to prepare monodispersed M-IONPs with diameter rang-
ing from 3 to 50 nm are of the form: (I) metal acetylacetonate—[M(acac)
n
] (where M = Fe, Co, 
Ni, Mn, Cr; n = 2 or 3) [52]; (II) metal cupferronates—[Mx(cup)
x
] (where cup = N-nitrosophen
ylhydroxylamine); (III) metal oxalate—[M(C
2
O
4
)
n
•2H
2
O]; (IV) metal carbonyl—Fe
3
(CO)
12
 [53] 
or Fe(CO)
5
 [50]; (V) metal acetate—[M(CH
3
COO)
n
]; (VI) metal carboxylate, (VII) metal-urea 
complex—[Fe(CON
2
H
4
)
6
](NO
3
)
3
 [54]; (VIII) Prussian Blue—Fe
4
[Fe(CN)
6
•14H
2
O] [55, 56]; (IX) 
metal chloride and (X) ferrocene—Fe(C
2
H
5
)
2
 [57].
Using the thermal decomposition method, it can be easy to control the size and morphology of 
magnetic nanoparticles by controlling the ratio of the starting reagents, i.e. the ratio between 
the organometallic compounds, surfactant and solvent. Reaction time, temperature and aging 
period are equally important for the control of size and morphology. Hyeon obtained mono-
dispersed iron oxide nanoparticles with size range from 4 to 20 nm by thermal decomposition 
of Fe(CO)
5
 in the presence of oleic acid at 100°C. Initially, he obtained an iron-oleic acid com-
plex, which was leaved to aging at high temperature (300°C) [50].
Pérez-Mirabet et al. used oleylamine both as stabilization agent (for the stabilization of the 
particles in solution) and as capping ligand (for the control of particles size), respectively, by 
one-pot thermal decomposition of Fe(acac)
3
 and M(acac)
2
 (M = Co, Mn, Cu and Zn) in oley-
lamine. They obtained magnetic spinel ferrite nanoparticles with average size of 12 nm and 
a saturation magnetization Ms = 76 emu/g, very close to the bulk magnetite (92 emu/g) [58].
This method is also suitable for synthesis of nanocubes and nanospheres, which are magnetic 
nanoparticles as well. Amara et al. synthesized Fe
3
O
4
 nanocubes and nanospheres by a new 
simple and single-step process [59]. They used various mixtures of ferrocene and polyvinylpyr-
rolidone (PVP) by solventless thermal decomposition. Lynch et al. obtained magnetic colloidal 
iron oxide nanoparticles by thermal decomposition. They generated gas bubbles (Ar) by boil-
ing solvents. Their results illustrated that the argon bubbles had a stronger effect on the nucle-
ation process of magnetic iron oxide nanoparticles than on their growth process [60]. Due to the 
nucleation process that involves boiling solvents, most often the accurate shape of the magnetic 
iron oxide nanoparticles is not fully reproducible using the thermal decomposition method.
3.3. Microemulsion method
A microemulsion is formed when a colloidal substance is dispersed in a solvent, that is not 
compatible with the substance (e.g. water and oil), through a surfactant. Finally, a microemul-
sion must be clear and stable, as long as it is an isotropic mixture of oil, water and surfactant. 
The surfactant forms a monolayer film at the oil/water interface, in which the hydrophilic head 
groups of the surfactant are dissolved in oil phase (consisting of a mixture of hydrocarbons 
and olefins) and the hydrophobic tail of the surfactant in the aqueous phase (consisting of 
metal salts) and vice versa, depending on the used surfactant. There are known two types of 
microemulsion: direct microemulsion, when the oil is dispersed in water and reversed micro-
emulsion, when the water is dispersed in oil. Both have been used to synthesize the magnetic 
iron oxide nanoparticles with tailored size and shape. The most common surfactants that are 
widely used in the fabrication of M-IONPs by microemulsion method are bis(2-ethylhexyl) sul-
fosuccinate (AOT), sodium dodecyl sulfate (SDS), cetyltrimethylammonium bromide (CTAB) 
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and poly-vinylpyrrolidone (PVP). Throughout time, the microemulsion method proved to be 
a simple and versatile method for fabrication of nanosized magnetic nanoparticles [61–65].
According to the literature, the size of the resulted nanoparticles can be controlled if the sur-
factant is proper chose and also by varying the ratio of water/oil/surfactant, the initial con-
centration of the reactants and the droplet size and by controlling the reaction temperature 
and time [66, 67]. The size of the synthesized nanoparticles can also be controlled in suitable 
narrow range by carrying out the reaction in nanoreactor [62, 64, 67].
Lu et al. demonstrated that the surfactant nature has an important role on the final properties 
of the nanoparticles [64]. The authors have investigated the effect of SDS (anionic surfactant), 
DTAB and CTAB (cationic surfactants) and non-ionic surfactant on the preformed crystal, on 
stoichiometric situations and on the magnetic properties of the resulted Fe
3
O
4
 nanoparticles. 
In all the cases, the authors have obtained Fe
3
O
4
 nanoparticles with size less than 16 nm, but 
in the case of using the cationic surfactants also obtained a good saturation magnetization, 
which is an essential parameter for biological applications.
Okoli et al. have prepared M-IONPs by the two types of microemulsion (water/oil and oil/
water), to be used in binding and separation of proteins. The authors demonstrated that by using 
a water/oil microemulsion, it can obtain magnetic iron oxide nanoparticles with a surface area 
of 147 m2/g compared to 304 m2/g for the magnetic nanoparticles obtained by oil/water micro-
emulsion [68, 69]. The M-IONPs specific surface area is inversely proportional with the size of 
nanoparticles, the higher is the specific surface area the smaller nanoparticles size is obtained.
The advantage of this method is the fact that it can be obtain magnetic nanoparticles with 
uniform morphology and controllable size; but the major drawbacks are the requirements of 
a large amount of solvent and the excess of surfactant that has to be eliminated.
3.4. Hydrothermal and solvothermal methods
In case of these methods, the reaction takes place in aqueous medium (the hydrothermal 
method) or in organic medium (solvothermal method), in reactors or autoclaves, at tempera-
tures between 130 and 250°C under high vapor pressure, in the range 0.3–4 MPa [70–72]. 
Using this method, it can be obtained magnetic iron oxide nanoparticles with tailored proper-
ties (size and shape) by tuning the reaction conditions. The hydrothermal method is known as 
an environment-friendly process for the obtaining of M-IONPs, due to the raw materials used 
such as sulfates and chlorides—as cation source, dissolved in water [73].
Lin et al. [74] has used hydrothermal and solvothermal methods to obtain hollow M-IONPs. 
Briefly, they used FeCl
3
 (as source of iron), ethylene glycol (as reducing agent), ammonium 
acetate and urea were used to guide the formation of hollow magnetite spheres. After homo-
geneous dispersion, the mixture is transferred to a Teflon-lined stainless steel autoclave and 
sealed to heat at about 200°C for 8–24 h. The authors demonstrated that the Fe3+ ions on 
the surface of the hollow spheres exist in the form of Fe
3
O
4
, and the results are confirmed 
by the Mössbauer measurements. Tian et al. synthesized ultra-small monodisperse Fe
3
O
4
 
nanoparticles, with precise size control of 1 nm, by solvothermal method [75]. They used 
Fe(acac)
3
 as iron source, n-octanol as a solvent and n-octylamine as a reductant. The authors 
obtained Fe
3
O
4
 nanoparticles with a size range from 4 to 6 nm, by varying the volume ratios 
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Figure 4. The general scheme for obtaining iron oxide magnetic powders using the combustion method.
of n-octylamine and n-octanol, without the need of a gas (N
2
) bubbling or reflux conditions. 
By comparing this method with the thermal decomposition methods for obtaining Fe
3
O
4
 
nanoparticles, this solvothermal process was more convenient.
Stoia et al. [14] synthesized Fe
x
O
y
 and Fe
x
O
y
/C nanocomposite by solvothermal method, with 
the purpose of using these nanocomposites as adsorbents for methylene blue removal from 
aqueous solutions. The authors used FeCl
3
 as iron source, 1,2-propanediol as solvent and 
diethylamine as precipitating agent. The activated carbon was introduced into system in order 
to obtain homogenous Fe
x
O
y
/C composites with high specific surface area and magnetic prop-
erties. Some researchers have attempted to modify the hydrothermal process. Ahmadi et al. 
obtained Fe
3
O
4
 nanoparticles at low temperature (140°C) without having to autoclave. They 
have studied kinetics of the reaction, but the magnetic properties of the resulted nanoparticles 
are inadequate in short reaction time (below 2 hours) [76].
As advantages, the hydrothermal and solvothermal methods are suitable for obtaining shape-
controlled M-IONPs. As a disadvantage, in the case of hydrothermal technique, the reaction 
takes place for a long time and the amounts of resulting products are low [76].
3.5. Combustion method
The combustion method is an alternative to the currently used methods, being barely men-
tioned in the literature for the synthesis of M-IONPs. The combustion method have a lot 
of advantages due to the simplicity of the working technique, short reaction time and low 
energy consumption, being in the same time environmentally friendly.
The combustion method involves the strong exothermic redox reaction between an oxidizing 
agent (iron nitrate) and various reducing agents (fuels) of organic nature. The initiation of the 
combustion process takes place by rapidly heating the mixture of raw materials at relatively 
low temperatures below 500°C (Figure 4). The reaction stoichiometry has a decisive role in 
the characteristics of the reaction product, especially in the granule size, since a combustion 
reaction does not occur for any molar fuel/oxidizing agent ratio.
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The use of metallic nitrates in a mixture with a suitable fuel has the great advantage that, fol-
lowing the combustion reaction, the gases are released without a high risk of toxicity: CO
2
, 
N
2
 and H
2
O [77]. By using a proper fuel, proper auxiliary additives, as well as an appropriate 
oxidizing agent/fuel ratio, it can be tailored the size of the particles, the specific surface area 
and the crystallinity degree of the obtained material [78, 79].
Ianoş et al. reported a new combustion synthesis technique for the preparation of nanosized 
Fe
3
O
4
 nanoparticles [80]. The authors developed a new, facile and cheap scheme of installa-
tion for combustion synthesis of Fe
3
O
4
 nanoparticles in the absence of air. They also investi-
gated the effect of both the reaction atmosphere (in the presence or in the absence of air) and 
the fuels nature on the properties of the resulted nanoparticles. Using sucrose, citric acid and 
glucose as fuels, the authors demonstrated that the reaction atmosphere is very important 
for obtaining Fe
3
O
4
 nanoparticles as a single crystalline phase. There were obtained Fe
3
O
4
 
nanoparticles in the size range of 10 (when glucose was used as fuel) to 18 nm (when citric 
acid was used as fuel).
Mihoc et al. also investigated the effect of both the fuels nature and the reaction atmosphere 
for obtaining magnetic nanoparticles used as adsorbent for the removal of phenol and p-chlo-
rophenol from wastewater [81]. The authors revealed that the working atmosphere influences 
the phase composition of the combustion reaction product. Using urea with ammonium chlo-
ride as fuels, the final product of reaction was α-Fe
2
O
3
 (when the reaction took place in air). 
Working in the absence of air, using oxalic, tartaric and citric acid as fuel, the single phase 
resulted in combustion reaction was Fe
3
O
4
, irrespective of the nature of the fuel.
Using the combustion method, the magnetic oxide nanoparticles are covered with some 
organic residues resulting from fuel combustion. Mihoc et al. demonstrated that these materi-
als exhibit better adsorption capacity as compared with the naked magnetic oxides [82].
However, if it is desired to remove the residual carbon resulting from the combustion pro-
cess, Ianos et al. found a method in which the residual carbon was eliminated by washing 
the magnetic nanoparticles several times with H
2
O
2
. They revealed that by combustion reac-
tion between Fe(NO
3
)
3
•9H
2
O and C
6
H
12
O
6
 a black magnetic nanoparticle containing γ-Fe
2
O
3
 
and residual carbon was obtained. The authors demonstrated that by H
2
O
2
 treatment of the 
resulted magnetic nanoparticles the carbon was removed by chemical oxidation, from 32.7 to 
0.4%, and the color of the sample changed from black to reddish brown [83].
M-IONPs proved to be versatile due to the large range board of applications in medicine. 
Nanomedicine is an emerging field that offers new approaches but especially new solutions 
for many medical problems. For example, the discovery of antibiotics has been of historic 
importance, but over time, antibiotic resistance has become an issue and new approaches are 
therefore needed. Many groups of researchers have already demonstrated that the synergic 
effects of the antimicrobials agents (not only the antibiotics) with nanoparticles can be pro-
moted as a new method for the severe infection treatments, even with low antimicrobial doses.
For the biomedical uses, only the M-IONPs which fulfill the following requirements are 
proper: superparamagnetic properties at room temperature, large saturation of magnetiza-
tions, biocompatibility and sizes around 20 nm for in vivo administration. To convert the pure 
magnetic nanoparticles in biocompatible colloidal suspensions, many researchers have pro-
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posed the use of different polymers like covering agents or surfactants like starch, heparin, 
chitosan, dextran, oleic acid, polyethylene glycol (PEG), etc.
Polymer coating can be accomplished during or after the synthesis of magnetic nanoparticles. 
Polyethylene glycol (PEG) is a water-soluble, biocompatible hydrophilic polymer that can be 
used successfully in the synthesis of biocompatible nanoparticles with increased resistance 
to blood circulation [84]. Another alternative to covered magnetic nanoparticles is the use of 
copolymers that produce core-shell nanoparticles with possible applications in drug trans-
port (drug vector) [85].
The use of inorganic compounds such as gold, silver, silica gel and carbon as surfactants not 
only provides good stability to the nanoparticles but also allows functionalizing their surface 
by grafting certain biological ligands. Covering of magnetic nanoparticles with gold seems 
to be ideal because of its low reactivity; however, coating the magnetic nanoparticles directly 
with gold is very difficult due to the different nature of the two surfaces [86–89]. The silica gel 
is the most widely used compound in the preparation of functionalized iron oxide nanoparti-
cles surface, because it has several advantages: excellent biocompatibility, hydrophilicity, the 
feasibility of integrating other functional groups on the surface due to terminal silanol groups 
that can react with different coupling agents, provides good stabilization of the magnetic 
iron oxide nanoparticles in the solution, prevents the interaction between the nanoparticles 
thus preventing the agglomeration of the particles over time and ensures better encapsulation 
[90]. A very good coating of carbon layers provides an effective barrier against oxidation and 
acidic erosion of magnetic nanoparticles. It is therefore possible to synthesize carbon-coated 
magnetic nanoparticles that are thermally stable, biocompatible and also have high oxidation 
stability, which is crucial for certain applications [89].
4. In vitro biological impact
4.1. Magnetic iron oxide nanoparticle effect on normal cells
Iron ions play major biological roles in different physiological processes, including DNA syn-
thesis, oxygen transport, mitochondrial respiration, heme synthesis, and in metabolic func-
tions at central nervous system level (nitric oxide metabolism, oxidative phosphorylation and 
myelin and neurotransmitter synthesis). Moreover, iron proved to be an essential factor for 
an appropriate function of neurons by acting as cofactor for tyrosine hydroxylase, an enzyme 
with a critical role in dopamine synthesis and the viability of neural cells. A dysregulation 
of the iron homeostasis or transport leads to unbalanced physiological functions and cyto-
toxic reactions. The free intracellular Fe2+ ions react with hydrogen peroxide (H
2
O
2
) and deter-
mine the generation of reactive oxygen species (ROS), process known as Fenton reaction. 
An increased ROS concentration activates a cascade of events (release of iron ions into the 
cytosol by inducing an augmented permeability of the outer mitochondrial membrane and 
detrimental effects on lysosomal membrane; lipid peroxidation, damaged proteins, break of 
DNA chains and degradation of bases, mutations, deletions or translocations at nuclear level) 
that has as endpoint cell death. The pathologies that are associated with this type of cellular 
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damage are aging, cancer and neurodegenerative diseases [91]. Another mechanism of induc-
ing cell death by the iron ions is the apoptotic pathway via mitochondria, as follows: a high 
amount of iron ions into the mitochondria determine the opening of the mitochondrial transi-
tion pore, release of Ca2+ and cytochrome c and activation of apoptotic cascade [91, 92].
Based on these data, concerning the toxicity induced by iron ions, it is imperative to study the 
possible toxic effects induced by M-IONPs, mainly since these particles present a higher reac-
tivity as compared with the normal sized ones. The magnetic character of iron oxide nanopar-
ticles offers some advantages, including the capacity of this nanosized compounds to be driven 
to targeted sites by an external magnetic field, even to tissues and organs that are difficult to 
reach in normal conditions (blood brain barrier and central nervous system). M-IONPs pen-
etrate into the cells via receptor-mediated endocytosis and settle into the lysosomes, organelles 
characterized by the presence of an acidic medium, where it takes place the metabolization of 
the nanoparticles and free iron ions are released into the cell [91].
In a previous study, it was demonstrated that M-IONPs penetrate differentially into the neural 
cells (glial cells, primary neurons of the cerebellum, microglia, astrocytes, oligodendrocytes 
and Schwann cells), based on their dimensions: large size nanoparticles were absorbed by 
endocytosis, whereas small sized ones via pinocytosis [91, 93]. It was also proved that expo-
sure to M-IONPs has an impact on iron homeostasis by upregulating the proteins respon-
sible for iron storage or export from the cell and by downregulating the proteins expression 
involved in iron uptake [94].
Besides these positive features, application of an external magnetic field leads to accumulation 
of M-IONPs in target cells and potential toxicity. The accumulation of iron into the cells after 
exposure to M-IONPs seems to be dependent on several factors, such as (i) concentration and 
dose of M-IONPs (high concentrations require a longer period for elimination—several months, 
whereas M-IONPs in low concentrations can be eliminated within 3 weeks), size (small size 
nanoparticles cumulate in increased concentrations as compared to large size nanoparticles), 
shape (spherical nanoparticles present a longer degradation process due to a small contact sur-
face), coating (some coating agents may prolong the degradation process or may increase it), 
the functional groups (the positively charged functional groups present in M-IONPs structure 
increase their uptake by the cells) and cell type (microglia have a higher affinity for M-IONPs, 
whereas into the brain endothelial cells penetrate less nanoparticles) [91].
A significant number of studies sustained that M-IONPs exerted in vitro and in vivo toxicity. 
The main players responsible for toxic effects are considered to be the iron ions released from 
M-IONPs at lysosomal level, which react with hydrogen peroxide and lead to ROS generation 
[91]. Exposure of neural cells to M-IONPs was associated with a low concentration of ROS, but 
a reduced level of glutathione and mitochondrial membrane hyperpolarization [95]. Other 
studies conducted on healthy cell lines (both human and animal origin) pointed out that bare 
M-IONPs may induce cytotoxic effects via ROS generation, leading to cell death [96–98].
The oxidation state of iron (Fe2+ or Fe3+) plays a major role in determining the nanoparticles 
toxicity according to the studies that affirm that Fe3+ in Fe
2
O
3
 is more toxic than Fe2+ in Fe
3
O
4
 
and causes more DNA oxidation [91, 99].
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The concentration of M-IONPs is also important in the assessment of M-IONPs toxicity. In 
one of our previous studies developed on HaCat cells (human keratinocytes), it was shown 
that concentrations lower than 25 μg/mL did not induce toxicity in terms of viability and 
cytoskeleton changes (Figure 5) [100].
Shelat and coworkers indicated a dose-dependent cytotoxic effect of M-IONPs on mouse 
embryonic fibroblast (NIH 3 T3) [101]. It was also assessed the effect of negatively charged 
superparamagnetic iron oxide nanoparticles on heart cells and no changes in actin cytoskele-
ton were observed, whereas in the case of brain and kidney cells, a disruption of the actin cyto-
skeleton was detected, but some increased vascular permeability was seen after exposure [102].
Another sign of toxicity that was described after neural cells exposure to M-IONPs was rep-
resented by protein aggregation. In addition, it was shown that M-IONPs induce apoptosis 
of hepatocytes in a mitochondrial-dependent way consisting of upregulation of pro-apoptotic 
markers (Bax and Bad) and downregulation of bcl-2 (anti-apoptotic); decrease of mitochon-
drial membrane potential followed by the release of cytochrome c into the cytosol what leads 
to activation of caspases cascade and apoptosis induction (Figure 6) [91].
Based on the data that were presented in this section, it could be said that the mechanisms 
involved in M-IONPs toxicity are accumulation of iron ions, oxidative damage by generating 
reactive oxygen species, protein aggregation and apoptosis.
Mutagenic effects of M-IONPs on different murine and mammalian normal cell lines were 
clearly synthesized in an extensive review [103].
Figure 5. The impact of magnetite and maghemite obtained by combustion method on HaCat cell morphology after 24 h 
stimulation.
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4.2. Magnetic iron oxide nanoparticles effect on cancer cells
SPIONs (superparamagnetic iron oxide nanoparticles) are the most frequently used iron oxide 
nanoparticles in the biomedical applications due to their proper size (range between 50 and 
200 nm) and the magnetic properties responsible for the lack of particle aggregates in vivo. 
Another type of iron oxide nanoparticles is represented by USPIONs (ultra-small superpara-
magnetic iron oxide nanoparticles), which have a diameter lower than 50 nm. The mandatory 
features of M-IONPs that must be analyzed in order to establish the bioavailability and the 
possible interactions with endogenous compounds (proteins, immune system cells, etc.) are: 
(i) size (the recommendable size for biomedical applications is between 10 and 200 nm; the 
ones that are too big will be assimilated by liver and spleen cells, the ones that are too small 
will be filtrated by the kidneys and their life in the bloodstream is reduced); (ii) superpara-
magnetism and (iii) presence of a coating agent [104].
The affinity of liver, spleen, bone marrow and lymph nodes for SPIONs after their removal 
from the blood by the mononuclear phagocytic system (MPS) after intravenous administra-
tion represents the reason for the study of this type of nanoparticles as contrast agents but also 
for their use as delivery tools for chemotherapeutic agents. USPIONs due to their small size 
possess the capacity to escape macrophages of MPS surveillance and their circulation time is 
higher, but they also encounter macrophages in deeper compartments.
The changes concerning the surface of the nanoparticles by using a coating agent proved 
to exert multiple roles: to improve colloids stability, to enhance the bioavailability and the 
bloodstream half-life and to reduce precipitation and formation of conglomerates [104, 105]. 
M-IONPs were used as drug delivery agents and as contrast agents based on their potential 
to activate at cellular and molecular levels [105].
Figure 6. Mechanisms of toxicity induced by M-IONPs to normal cells (neural cells and hepatocytes): oxidative stress 
and apoptosis.
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Due to the multiple applications of M-IONPs in biomedical fields (drug delivery, as contrast 
agents, hyperthermia treatment), it was also verified the effects of the hollow nanoparticles 
(without payload) on different tumor cell lines.
As mentioned in the previous section, M-IONPs mediate DNA lesions in normal cells, and 
this property is also exerted in the case of tumor cells. The effect observed was dose-depen-
dent and time-dependent and consisted of damage of tail length and DNA strand breaks. The 
results were similar in all the tumor cell lines tested: human breast cancer cell line (MCF-7), 
human fibrosarcoma cells, lung cancer and cervix carcinoma cells [103].
Another mechanism of M-IONPs by which are able to harm cancer cells is represented by 
the ability to induce magnetic hyperthermia in the form of heat generated by the release of 
energy after applying a high-frequency alternating magnetic field. The principle of action of 
this technique consists in raising the cell temperature abnormally to 41–45°C, which leads to 
significant detrimental effects that can be reversible in the case of normal cells whereas irre-
versible for cancer cells [105].
A novel proposed mechanism for M-IONPs-induced cell death is enucleation described by 
Paunescu and coworkers, process observed after exposure of breast cancer cells (MCF-7) and 
human melanoma (SK-BR-3) to magnetic iron oxide nanoparticles obtained by combustion 
synthesis [106]. The enucleation phenomena is well described for erythroid terminal differen-
tiation process and there is also used a term in the literature “enucleation sign” that is specific 
for enhanced computed tomographic images of the ruptured hepatocellular carcinoma. The 
definition for this term is “the separation of tumor content with intraperitoneal rupture into 
the perihepatic space, which is seen as low attenuating lesion from peripheral enhancing rim 
on arterial phase imaging” [107]. The process observed by Paunescu et al. was described as 
a non-physiological process and it was unrelated with the process described for erythroblast 
enucleation [106].
The M-IONPs proved a cytotoxic effect against murine melanoma cells B16, cytotoxicity eval-
uated by the means of MTT viability assay [108].
Other mechanisms of action as anticancer agents may be attributed to M-IONPs, mechanisms 
that are related with the effects induced by the chemotherapeutical agents loaded in the engi-
neered nanoparticles. The large surface-to-volume ratio characteristic for M-IONPs make 
them suitable to adsorb proteins or load drugs and attractive for in vivo applications, such as 
MRI, drug and gene delivery, cancer treatment, hard tissue repair and tissue engineering and 
biosensors [105].
Recent studies mention the use of M-IONPs as improved contrast agents in the diagnosis of 
cardiovascular pathologies, mainly in atherosclerosis for detection of unstable plaques by 
the means of MRI (magnetic resonance imaging) [104]. The commercial products based on 
M-IONPs applied as contrast agents in MRI are: Ferumoxytol (Feraheme—detection of pri-
mary tumors and cancer lymph node metastasis), Ferumoxides (Feridex—detection of liver 
lesions), Ferucarbotran (Resovist—detection of small focal liver lesions), Ferumoxtran—10 
(Combidex or Sinerem—detection of metastatic disease in lymph nodes), etc. [104]. Some 
of these products are included in clinical trials for additional effects, such as Endorem—
for tracking monocytes and inflammation cells, Feridex—to keep track of adult bone 
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marrow-derived stromal cells for severe cases of Multiple Sclerosis therapy and Supravist 
(ferucarbotran—small size nanoparticles)—as enhancing blood pool agent [104, 109].
5. Concluding remarks
The intrinsic magnetic properties, the biocompatibility and biodegradability and the capacity to 
respond to an external magnetic field are unique features that recommend magnetic iron oxide 
nanoparticles as promising nanomaterials in biomedical applications. The recent advances in this 
field led to the synthesis of engineered and targeted M-IONPs that might be successfully applied 
for smart therapies, including controlled drug release, hyperthermia treatment, magnetofection 
and gene delivery, mapping of lymph nodes and tissue engineering. M-IONPs could be con-
sidered theranostics tools based on their capacity to combine their use in diagnostic, treatment 
and follow-up of a pathology. Despite all these beneficial effects, an important matter should be 
taken into consideration when M-IONPs are administered in vivo, this matter consisting in the 
thorough analysis of the factors that might induce toxic reactions like size, charge, coating agent, 
functional groups and shape. There are still some challenges to achieve M-IONPs optimum effi-
cacy and safety, but the existent drawbacks can be corrected by the improvement of their proper-
ties by the means of appropriate methods, further studies and inclusion in clinical trials.
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